Stryker Corp(SYK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 31.23 | EPS (ttm) | 9.65 | Insider Own | 5.88% | Shs Outstand | 383.6M | Perf Week | -0.98% |
| Market Cap | 115.62B | Forward P/E | 18.07 | EPS next Y | 11.54% | Insider Trans | -2.9% | Shs Float | 361.0M | Perf Month | 9.48% |
| Enterprise Value | 127.59B | PEG | 1.66 | EPS next Q | 3.55 | Inst Own | 82.65% | Short Float | 1.58% | Perf Quarter | -14.43% |
| Income | 3.73B | P/S | 4.47 | EPS this Y | 9.71% | Inst Trans | 1.11% | Short Ratio | 2.16 | Perf Half Y | -6.23% |
| Sales | 25.84B | P/B | 4.82 | EPS next 5Y | 10.9% | ROA | 7.91% | Short Interest | 5.70M | Perf YTD | -14.24% |
| Book/sh | 62.54 | P/C | 33.26 | EPS past 3/5Y | 10.83% 14.84% | ROE | 16.51% | 52W High | -22.58% ($389.33) | Perf Year | -21.45% |
| Cash/sh | 9.06 | P/FCF | 24.59 | Sales past 3/5Y | 10.83% 11.84% | ROIC | 9.68% | 52W Low | 12.89% ($267.00) | Perf 3Y | 15.09% |
| Dividend Est. | $3.53 (1.17%) | EV/EBITDA | 17.03 | EPS Y/Y TTM | 27.36% | Gross Margin | 62.97% | Volatility(W/M) | 2.54% 2.62% | Perf 5Y | 12.26% |
| Dividend TTM | 3.52 | EV/Sales | 4.94 | Sales Y/Y TTM | 8.48% | Oper. Margin | 24.27% | ATR (14) | 8.11 | Perf 10Y | 174.72% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 1.33 | EPS Q/Q | 44.49% | Profit Margin | 14.43% | RSI (14) | 57.96 | Recom | 1.62 |
| Dividend Gr. 3/5Y | 6.31% 7.67% | Current Ratio | 2.16 | Sales Q/Q | 9.42% | SMA20 | 4.42% ($288.66) | Beta | 0.8 | Target Price | $364.48 |
| Payout | 40.48% | Debt/Eq | 0.64 | Earnings | 2026/10/29 | SMA50 | 2.34% ($294.53) | Rel Volume | 0.86 | Prev Close | $306.13 |
| Employees | 56000 | LT Debt/Eq | 0.61 | EPS/Sales Surpr. | 5.78% 0.15% | SMA200 | -7.16% ($324.67) | Avg Volume(3M) | 2.64M | Price | $301.42 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 36489 | Volume | 2,265,661 | Change | -1.54% |
🦴 A global medical device company with an extensive medical device portfolio spanning orthopedics, neurosurgery, surgery, and emergency medicine. Founded in the United States in 1941 and headquartered in Kalamazoo, Michigan, it holds a leading position in the orthopedic surgical robotics (MAKO) and implant market, as well as in the surgical and emergency medical device markets.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
Traded about as much as usual. That is 86% of its average volume.
Next earnings report: October 29
1 days to go.
SYK makes money exceptionally well
Of every $100 in sales, $24.27 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.7% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,703. Peers typically go for $1,594. Compared with its own 5-year average, it is 25% cheaper now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be +12.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.17% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 82.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 142 in the industry
Based on market cap of $116B.
Earnings Analysis · 7/30 Stryker ($SYK) Q2 2026 Earnings Analysis — Revenue and Adjusted EPS Beat Expectations, Shares Plunge After-Hours Despite Narrowed Outlook Investing Guides · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is SYK?
SYK belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SYK?
The market cap of SYK is approximately $115.6B, ranking 139 within its sector.
Does SYK pay dividends?
SYK has a dividend yield of approximately 1.17%, with an annual dividend of $3.53.
What is the P/E ratio of SYK?
SYK has a P/E ratio of approximately 31.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SYK?
SYK has recorded a 52-week high of $389.33 and a low of $267.00.
